Sherene Loi

Sherene Loi is an Australian Medical oncologist. She is the 2021 winner of the Australian Prime Ministers Prize for Science, in the category of Frank Fenner Prize for Life Scientist of the Year. Loi is Head of Translational Breast Cancer Research, within the Peter Macallum Cancer Centre. Loi's research has advanced understanding into breast cancer, developing and implementing an immune system biomarker. This biomarker will enable improved management for people with advanced cancer. This biomarker is now part of routine pathology reporting across many countries and also is included in the World Health Organization Classification of Tumours (the WHO Blue Book on Breast Tumors). Provided by Wikipedia
Showing 1 - 4 results of 4 for search 'Sherene Loi', query time: 0.02s Refine Results
  1. 1
    Preliminary characterisation of the spatial immune and vascular environment in triple negative basal breast carcinomas using multiplex fluorescent immunohistochemistry.

    Preliminary characterisation of the spatial immune and vascular environment in triple negative basal breast carcinomas using multiplex fluorescent immunohistochemistry. by Elena A Takano, Metta K Jana, Luis E Lara Gonzalez, Jia-Min B Pang, Roberto Salgado, Sherene Loi, Stephen B Fox

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial

    Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial by Mattia Rediti, David Venet, Andrea Joaquin Garcia, Marion Maetens, Delphine Vincent, Samira Majjaj, Sarra El-Abed, Serena Di Cosimo, Takayuki Ueno, Miguel Izquierdo, Martine Piccart, Lajos Pusztai, Sherene Loi, Roberto Salgado, Giuseppe Viale, Françoise Rothé, Christos Sotiriou

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

    Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease by Bart Neyns, Mark Middleton, Aurélien Marabelle, Ignacio Melero, Ke Liu, Nina Bhardwaj, Tanja D de Gruijl, Jason Chesney, Robert Coffin, Howard Kaufman, Diwakar Davar, Jason J Luke, Georgina V Long, Kevin J Harrington, Sherene Loi, Thierry de Baere, David J Pinato, Matthew Fury, Ciara M Kelly, Joshua D Brody, Robert H Andtbacka, Gregory Goldmacher, Anuradha D Khilnani, Rahul A Sheth, Stephen B Solomon, Philippe Szapary

    Published 2024-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Consensus guidelines for the definition, detection and interpretation of immunogenic cell death by Udo S Gaipl, Dmitriy Zamarin, Felipe Prosper, Francesco M Marincola, Alessandra Cesano, Howard L Kaufman, Laurence Zitvogel, Tim Illidge, Taha Merghoub, Sandra Demaria, Abhishek D Garg, Patrizia Agostinis, James W Hodge, George Coukos, Akseli Hemminki, Öystein Rekdal, Jian Han, John Stagg, Sarah Warren, Lorenzo Galluzzi, Dobrin Draganov, Silvia C Formenti, Mark J Smyth, Radek Špíšek, Michael T Lotze, Takahiro Yamazaki, Guido Kroemer, Daolin Tang, Eric Deutsch, Jitka Fucikova, Sofia R Gameiro, Ilio Vitale, Sandy Adjemian, Aitziber Buqué Martinez, Timothy A Chan, Richard L Edelson, Lucia Gabriele, Encouse Golden, Kevin J Harrington, Dewan Md Sakib Hossain, Michael Karin, Oliver Kepp, Juan Jose Lasarte, Sherene Loi, Gwenola Manic, Alan A Melcher, Karen L Mossman, Maria Rescigno, Chiara Riganti, Antonella Sistigu, Bryan E Strauss, Kazuki Tatsuno, Stefaan W van Gool, Peter Vandenabeele

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: